Answers are grounded in this paper and cite their sources.
Our data point to an important role for targeted multigene panels in diagnosing hereditary cancer predisposition, particularly for patients with clinical histories spanning several possible diagnoses and for patients with suspicious clinical histories not meeting diagnostic criteria for a specific hereditary cancer syndrome.
No takes yet. Share an insight, caveat, or question.
LaDuca et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: